UNITED HEALTH PRODUCTS, INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Apr 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | — | — | $0 | — | — | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $3.9K | — | — | $12.6K | — | — | $25.3K |
| SG&A Expense | — | $163.0K | — | — | $253.0K | — | — | $207.8K |
| Operating Income | — | $-166.9K | — | — | $-265.6K | — | — | $-233.2K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | $50.5K | — | — | $48.1K | — | — | $30.7K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-284.1K | — | — | $-315.8K | — | — | $-285.6K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | $0.00 | — | — | $0.00 | — | — | $0.00 |
| Shares Outstanding (Basic) | 262.7M | — | 260.4M | 258.7M | — | 258.7M | 258.7M | — |
| Shares Outstanding (Diluted) | 262.7M | 260.0M | 260.4M | 258.7M | 258.7M | 258.7M | 258.7M | 257.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |